NCT07744763 — Advanced Solid Tumors trial site landscape

Public-registry site landscape for NCT07744763, “A Phase I/IIa Study of SYS6041 in Patients With Advanced Solid Tumors”, a Advanced Solid Tumors study sponsored by CSPC Megalith Biopharmaceutical Co.,Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07744763 (registry record)
Study title	A Phase I/IIa Study of SYS6041 in Patients With Advanced Solid Tumors
Official title	A Multicenter, Open-label, Dose-escalation and Dose-expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Antitumor Activity of SYS6041 in Patients With Advanced Solid Tumors
Sponsor	CSPC Megalith Biopharmaceutical Co.,Ltd.
Condition(s)	Advanced Solid Tumors
Phase	PHASE1 / PHASE2
Listed sites	1
Site countries	China

Patient-friendly overview of this study: eichor.com/study/NCT07744763.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07744763 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →